<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The use of <z:chebi fb="2" ids="35475">nonsteroidal anti-inflammatory drugs</z:chebi> (<z:chebi fb="1" ids="35475">NSAIDs</z:chebi>) and <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> increases the risk of upper <z:hpo ids='HP_0002239'>gastrointestinal bleeding</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This article assesses its incidence in patients undergoing hip and knee arthroplasty </plain></SENT>
<SENT sid="2" pm="."><plain>A single-center, retrospective study was conducted on 100 consecutive hip and 100 consecutive knee arthroplasties performed at the Victoria Infirmary, Glasgow, between 1998 and 2000 </plain></SENT>
<SENT sid="3" pm="."><plain>Sixty-three percent of patients were women with a mean age of 74 </plain></SENT>
<SENT sid="4" pm="."><plain>Fifty-four percent of patients received <z:chebi fb="1" ids="35475">NSAIDs</z:chebi> and <z:hpo ids='HP_0000001'>all</z:hpo> patients received <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> perioperatively </plain></SENT>
<SENT sid="5" pm="."><plain>Four and a half percent of patients had upper <z:hpo ids='HP_0002239'>gastrointestinal bleeding</z:hpo> postoperatively </plain></SENT>
<SENT sid="6" pm="."><plain>We believe that the incidence of upper <z:hpo ids='HP_0002239'>gastrointestinal bleeding</z:hpo> as a complication is underestimated and recommend gastro-<z:chebi fb="1" ids="50267">protective agents</z:chebi> in the perioperative period for patients on <z:chebi fb="1" ids="35475">NSAIDs</z:chebi> </plain></SENT>
</text></document>